Between 2013 and 2023, the market size of Penicillins and Streptomycins in Germany, expressed in USD per capita, experienced fluctuations. It peaked in 2021 at $6.16 and ended at $5.7 in 2023. Over the past two years, 2022 saw a decrease to $5.65, and 2023 experienced a slight rebound to $5.7, indicating a minor year-on-year growth. The 5-year Compound Annual Growth Rate (CAGR) shows stability.
Future trends to watch include the impact of emerging antibiotic resistance, potential regulatory changes, and innovations within the pharmaceutical industry that might influence demand and market dynamics in Germany.
| # | 31 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 11.76 | 2023 | View data | ||
| 2 | 2 New Zealand | 11.59 | 2023 | View data | ||
| 3 | 3 France | 11.21 | 2023 | View data | ||
| 4 | 4 Belgium | 11.17 | 2023 | View data | ||
| 5 | 5 United Kingdom | 10.77 | 2023 | View data | ||
| 6 | 6 Australia | 10.14 | 2023 | View data | ||
| 7 | 7 Canada | 7.4 | 2023 | View data | ||
| 8 | 8 Germany | 5.7 | 2023 | |||
| 9 | 9 Switzerland | 5.65 | 2023 | View data | ||
| 10 | 10 Croatia | 5.57 | 2023 | View data | ||
